CLINICAL_TRIALS
research
· 2010-10-11
Clinical Trial Update: Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs
Summary
A clinical trial update describing a study that analyzes circulating tumoral DNA in Neurofibromatosis Type 1 patients with malignant peripheral nerve sheath tum…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: KU Leuven | Conditions: Neurofibromatosis Type 1 | Status: UNKNOWN